Thu, 31 Jul 2003:
Pfizer, the US drugs group, is considering the sale of its surgical opthalmology business, which generates $150m in annual turnover. The division has manufacturing facilities in the Netherlands and Sweden. Pfizer is being advised by Morgan Stanley. ...
[more: Pfizer, the US drugs group, is consideri...]
